ENTG — Entourage Health Income Statement
0.000.00%
- CA$1.54m
- CA$179.83m
- CA$40.71m
- 45
- 85
- 23
- 50
Annual income statement for Entourage Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 20.8 | 29.4 | 42.3 | 40.9 | 40.7 |
Cost of Revenue | |||||
Gross Profit | -5.69 | -40.9 | -14.2 | -15.4 | 5.44 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 29.2 | 117 | 115 | 146 | 64.2 |
Operating Profit | -8.36 | -87.7 | -73.1 | -105 | -23.5 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.4 | -89.6 | -78.9 | -123 | -46.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.4 | -89.6 | -78.9 | -123 | -46.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -10.4 | -89.6 | -78.9 | -123 | -46.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.4 | -89.6 | -78.9 | -123 | -46.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.267 | -0.362 | -0.208 | -0.211 | -0.138 |